Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
Short Communication
2002:68:4;217-219
PMID: 17656941

Effect of phenytoin sodium in reducing blistering of epidermolysis bullosa report of four cases

CK Sasidharan, M Vijayakumar, MS Vinodkumor
 Department of Paediatrics, IMCH, Calicut-673 008, India

Correspondence Address:
C K Sasidharan
Department of Paediatrics, IMCH, Calicut-673 008
India
How to cite this article:
Sasidharan C K, Vijayakumar M, Vinodkumor M S. Effect of phenytoin sodium in reducing blistering of epidermolysis bullosa report of four cases. Indian J Dermatol Venereol Leprol 2002;68:217-219
Copyright: (C)2002 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

To evaluate the effect of phenytoin in reducing of patients with epidermolysis bullosa four newborn babies were studied after thorough clinical evaluation including detailed history and relevant investigations. All of them were put on oral phenytoin sodium, in the usual antiepileptic dose and were followed up. All of the babies had significant reduction in the number of lesions.
Keywords: Phenvtoin sodium, Epidermolysis bullosa

Introduction

Epidermolysis bullosa (EB) is a genetic disorder which follows simple mendelian inheritance pattern with exception of EB acquisita, the exact inheritance pattern of which is not clear.[1],[2],[4] Defects in any one of the genes that codes for critical skin proteins like collagen and keratin are thought to be responsible for this condition.[1],[2] Some in vitro studies have demonstrated that phenytoin inhibits synthesis or secretion of collagenase, when it was added to human skin explant and fibroblast cultures.[7]

Subjects and Methods

Four neonates were studied after thorough clinical evaluation including detailed history and relevant investigations.

Case 1

A 2-day-old male baby, appropriate for gestational age was admitted with history of bullous lesions noted on second day of life over both lower limbs. Baby was born by normal labour to a primigravida of non consanguineous marriage who had no significant illness either before or during pregnancy. There was no family history of similar illness. Within two days, there was involvement of upper limbs and trunk and three days later nails also were affected. [Figure - 1], [Figure - 2]

Case 2 and 3

These babies were twins, both being low birth weight born by normal labour to a third gravida of non-consanguineous marriage. Mother had no significant illness, except for the fact that the second pregnancy was aborted at two months. Both babies were admitted on third day of life with bullae noted on the upper and lower limbs as well as on the trunk. Later there was involvement of face as well as nails.

Case 4

This male baby was fifth of second degree consanguineous parents and was term AGA bay born normally. Third pregnancy of mother was aborted at two and a half month and fourth baby died at first month of life due to epidermolysis bullosa. This baby had bullae over trunk and limbs with involvement of nails.

All these babies had blisters over areas of skin which are vulnerable to pressure and Nikilsky′s sign was positive. Serological test (Blood VDRL) of mothers for syphilis was negative. Tzanck smear from lesions were taken but was negative. Babies didn′t have any clinical or serological evidence of intrauterine infection. Biopsy from lesions showed that blisters were subepidermal with cleavage beneath the PAS positive basement membrane on light microscopy.

All babies were put on oral phenytoin in a dose of 5mg/Kg/day. Precautions were taken to avoid trauma to skin by keeping babies on plantain leaves. Antibiotics were given prophylactically and local antibiotic cream was also applied. Babies were kept in isolation in newborn nursery. They were periodically evaluated including photographs to document decrease in percentage of blistering. They were specifically followed up for development of anemia, hypoproteinemia and super added infections. Peripheral smear was evaluated periodically to rule our thrombocytopenia. Regular weight recording was done to assess nutritional status.

All the babies had significant reduction in the number of lesions. When the already present lesions were healed, new lesions did not appear even when we subjected the skin to trauma by rubbing the skin. Objective assessment was done by counting the number of blisters over a two square cm surface area before initiation of treatment and after two weeks of treatment.

Discussion

Epidermolysis bullosa is a rare genetic disorder. There are three main types-simplex, junctional and dystrophic.[1],[4] Most are inherited as autosomal recessive and some dominant.[4] In EB simplex, blister cleavage is intraepidermal, in junctional EB it is intra lamina densa and in dystrophic type, below lamina densa ie sublamina densa.[1],[2],[4] There are 25-30 subtypes of EB and of these only two are considered lethal ie the junctional Herlits which is deadly to the newborn and recessive dystrophic EB-Ha Ilopean-Siemens (Gravis) type.[1],[2],[3] [Figure - 3]

One variety (subtype) of EB simplex, Dowling Meara variant, is often confused with recessive dystrophic type because clinical manifestations are similar. Milia, nail involvement, oral blistering are seen in both.[4],[5] All the four babies which we studied had clinical features suggestive of either of these two forms of EB and biopsy confirmed the diagnosis of dystrophic EB. [Figure - 4]

Phenytoin is a commonly used antiepi-leptic given in maintenance dose of 5mg/Kg/day after a loading dose of 1020mg/Kg/day.[6] Common side effects of the drug are-hirsutism, gum hyperplasia, ataxia, skin rashes and Stevens Johnson syndrome, megaloblastic anemia, polyneuropathy and rickets.[6] Gum hyperplasia appears to be due to altered collagen metabolism. The metabolite of phenytoin 5(p-HPPH) has been implicated.[6] In vitro studies have demonstrated that phenytoin inhibits synthesis or secretion of collagenase.[7] This ability may be responsible for the beneficial effect of phenytoin in patients with EB.

Eventhough only four cases were studied, our study shows that phenytoin if used judiciously is safe and effective in reducing blistering and thereby improving outcome in lethal forms of EB like dystrophic EB.

References
1.
Pearson RW. Studies on the pathogenesis of epidermolysis bullosa. J Invest Dermatol 1962;39:551-575.
[Google Scholar]
2.
Eugene A, Bauer, Briggaman RA. Hereditary epidermolysis bullosa. In: Dermatology in General Medicine, Fitzpatrick TB, Eisen AZ, Wolf K et al. Mc Grow Hill, 1993;654-669.
[Google Scholar]
3.
Pearson RW, Potter B, Strauss F. Epidermolysis bullosa hereditaria lethalis: Clinical and histological manifestations and course of the disease. Arch Dermatol 1974;109:349-355.
[Google Scholar]
4.
Fine JD, Bauer EA, Briggaman RA, et al. Revised clinical laboratory criteria for subtypes of inherited epidermolysis bulloo. J Am Acad Dermatol 1991;24:119-135.
[Google Scholar]
5.
Anton Lamrecht I, Schnyder UW. Epidermolysis bullosa herpetiformis Dowling Meara variant. Report of a case and pathomorphogenesis. Dermatologica 1982;164:221-223.
[Google Scholar]
6.
Iciri I, Goto W, Hirata K, et al. Effect of 5 (p-hydroxyphenyl) 5 phenyl hydantion (p-HPPH) enantiomers major metabolites for phenytoin on the occurrence of chronic gingival hyperplasia, in vivo and in vitro study. Eur J Clin Pharmacol, 1995;49:5-56.
[Google Scholar]
7.
Bauer EA, Cooper TW, Tucker DR, et al. Phenytoin therapy of recessive dystrophic EB. Clinical trial and proposed mechanism of action on collagenase. N Engl J Med 1980;303:776-781.
[Google Scholar]
Show Sections